AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System in Treatment of Pulmonary Embolism
October 31st, 2022
Announcements
AngioDynamics Announces FDA Clearance of Expanded Indications for Auryon Atherectomy System
August 5th, 2022
Announcements
AngioDynamics, The PERT Consortium™ Launch APEX-AV Study Assessing AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE System in Treatment of Pulmonary Embolism
April 28th, 2022
Announcements
New Clinical Study to Assess Auryon Atherectomy Treatment in Below-the-Knee Arteries
April 14th, 2022
Announcements
First Patients Treated in PRESERVE Clinical Study
April 14th, 2022
Announcements
AngioDynamics to Present at the Needham Virtual Growth Conference
January 6th, 2022
Announcements
AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022
December 15th, 2021
Announcements
AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance
September 30th, 2021
Announcements
AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021
September 15th, 2021
Announcements
New AMA Category III CPT Code Issued for Transcatheter Removal/Debulking of Intracardiac Masses
August 30th, 2021
Announcements
AngioDynamics Receives FDA Approval for PRESERVE Study
August 12th, 2021
Announcements
AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference
July 29th, 2021
Announcements
AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
July 13th, 2021
Announcements
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021
July 8th, 2021
Announcements
AngioDynamics to Report Fiscal 2021 Fourth Quarter and Full-Year Financial Results and Host Investor & Technology Day on July 13, 2021
June 24th, 2021
Announcements
AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System
June 8th, 2021
Announcements
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
May 17th, 2021
Announcements
AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System
April 12th, 2021
Announcements
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 5th, 2021
Announcements
AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
March 30th, 2021
Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
March 15th, 2021
Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the Oppenheimer Healthcare Conference
March 9th, 2021
Announcements
Using AI to Predict Clinical Trial Success
February 10th, 2021
Announcements
AngioDynamics Appoints Richard C. Rosenzweig Senior Vice President, General Counsel and Secretary, Promotes Juan Carlos Serna to Senior Vice President, Scientific & Clinical Affairs
February 1st, 2021
Announcements
AngioDynamics Reports Fiscal 2021 Second Quarter Financial Results
January 7th, 2021
Announcements
AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
January 4th, 2021
Announcements
AngioDynamics to Present at the Needham Virtual Growth Conference
December 29th, 2020
Announcements
AngioDynamics Announces Presentation of Positive Safety, Efficacy Results from RAPID Outcomes Database
November 12th, 2020
Announcements
AngioDynamics Reports Fiscal 2021 First Quarter Financial Results
September 29th, 2020
Announcements
AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States
September 21st, 2020
Announcements
AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020
September 17th, 2020
Announcements
AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System
August 17th, 2020
Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference
August 3rd, 2020
Announcements
AngioDynamics Receives FDA Clearance and CE Mark for SmartPort+ Implantable Port
July 27th, 2020
Announcements
AngioDynamics’ Response to the Coronavirus (COVID-19) Outbreak
July 21st, 2020
Announcements
AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results
July 16th, 2020
Announcements
AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020
June 23rd, 2020
Announcements
AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference
June 8th, 2020
Announcements
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
May 7th, 2020
Announcements
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
April 7th, 2020
Announcements
AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
March 10th, 2020
Announcements
AngioDynamics to Present at Two Investor Conferences in March
February 27th, 2020
Announcements
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
February 6th, 2020
Announcements
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
January 16th, 2020
Announcements
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
January 7th, 2020
Announcements
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
January 6th, 2020
Announcements
AngioDynamics to Report Fiscal 2020 Second Quarter Financial Results on January 7, 2020
December 10th, 2019
Announcements
AngioDynamics Hosts “Beacon of Hope” Event to Mark Pancreatic Cancer Awareness Month
November 5th, 2019
Announcements
AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology
October 3rd, 2019
Announcements
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
October 3rd, 2019
Announcements
AngioDynamics Awarded Premier’s Nationally Outsourced Implantable Infusion Port Agreement
September 9th, 2019
Announcements
AngioDynamics to Report Fiscal 2020 First Quarter Financial Results on October 3, 2019
September 5th, 2019
Announcements
AngioDynamics Announces Appointment of Former Johnson & Johnson Executive Karen Licitra to its Board of Directors
July 31st, 2019
Announcements
AngioDynamics to Present at the Canaccord Genuity Growth Conference
July 23rd, 2019
Announcements
AngioDynamics Reports Fiscal 2019 Fourth Quarter and Full-Year Financial Results
July 10th, 2019
Announcements
AngioDynamics to Report Fiscal 2019 Fourth Quarter and Full-Year Financial Results on July 10, 2019
June 20th, 2019
Announcements
AngioDynamics to Present at the Raymond James Life Sciences and MedTech Conference
June 4th, 2019
Announcements
AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc.
June 3rd, 2019
Announcements
AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange
May 28th, 2019
Announcements
AngioDynamics Receives FDA Approval to Initiate Pilot Study for the Use of NanoKnife® to Treat Prostate Cancer
May 22nd, 2019
Announcements
AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
May 13th, 2019
Announcements
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million
April 17th, 2019
Announcements
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer
April 17th, 2019
Announcements
AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results
April 2nd, 2019
Announcements
AngioDynamics to Present at the Needham Healthcare Conference
April 1st, 2019
Announcements
AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
April 1st, 2019
Announcements
OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy
March 28th, 2019
Announcements
AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019
March 12th, 2019
Announcements
AngioDynamics Wins Patent Infringement Dispute With Bard
March 8th, 2019
Announcements
AngioDynamics to Present at the Barclays Global Healthcare Conference
February 26th, 2019
Announcements
AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results
January 4th, 2019
Announcements
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
December 20th, 2018
Announcements
AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019
December 10th, 2018
Announcements
AngioDynamics Reports Fiscal 2019 First Quarter Financial Results
September 27th, 2018
Announcements
AngioDynamics to Present at the Cantor Global Healthcare Conference
September 19th, 2018
Announcements
AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac® Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio
September 13th, 2018
Announcements
AngioDynamics to Report Fiscal 2019 First Quarter Financial Results on September 27, 2018
September 13th, 2018
Announcements
AngioDynamics to Present at Two Investor Conferences in September
August 23rd, 2018
Announcements
AngioDynamics Provides Updates on Oncology and Vascular Access Businesses
August 15th, 2018
Announcements
AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018
June 21st, 2018
Announcements
